$928.75
+38.34 (+4.31%)
As of Feb 15, 2:03 AM ET ·
GS News30 articles
Morgan Stanley Recovers as Inflation Data Eases Rate Fears
Morgan Stanley stock climbed 1.8% to $171.15 Friday, recovering part of Thursday's 4.9% decline. Softer inflation figures eased interest rate concerns, though regulatory and Fed policy uncertainty persists.
Markets 14h ago
Goldman Sachs Legal Chief Exits Amid Epstein Scandal Fallout
Goldman Sachs' top lawyer Kathy Ruemmler steps down following disclosures about her past interactions with Jeffrey Epstein, as the bank's shares face volatility.
Regulation 18h ago
Morgan Stanley CEO's Compensation Climbs to $45 Million for 2025
Morgan Stanley CEO Ted Pick received $45 million in total compensation for 2025, up from $34 million the prior year, with most of the award deferred and tied to performance.
Markets yesterday
JPMorgan Faces Class Action on Sweep Rates as Stocks Head for Weekly Loss
JPMorgan Chase shares edged higher Friday as a U.S. judge permitted parts of a class action over low cash-sweep rates. The broader market declined, heading for its worst week since November.
Regulation yesterday
Goldman Sachs Legal Chief Exits Amid Epstein Scrutiny as Stocks React to CPI Data
Goldman Sachs Group Inc. saw its stock dip following the resignation of Chief Legal Officer Kathy Ruemmler, linked to her past association with Jeffrey Epstein. The move coincided with a softer-than-expected inflation reading that influenced broader market sentiment.
Markets yesterday
Morgan Stanley Drops 4% as Inflation Data, AI Concerns Weigh on Financials
Morgan Stanley declined over 4% Thursday as investors positioned for U.S. inflation data and questioned AI's impact on fee-based businesses. Financial stocks broadly retreated.
Markets 2d ago
Goldman Sachs Shares Slide 3.8% Amid Sector-Wide Retreat Ahead of CPI
Goldman Sachs shares dropped 3.8% to $908.84 Thursday, mirroring a broad decline in financial stocks as markets await Friday's crucial inflation report.
Markets 2d ago
JPMorgan Shares Retreat as Robust Jobs Data Dampens Fed Rate Cut Expectations
JPMorgan Chase stock reversed early gains, closing 0.5% lower after a strong U.S. employment report reduced bets on imminent Federal Reserve rate cuts. Attention now pivots to Friday's inflation data.
Markets 3d ago
KKR Holds Near $107 as CFO Reiterates 2026 Profit Goal Amid Macro Caution
KKR shares steadied around $107.45 after a recent 4% surge, with CFO Rob Lewin reaffirming a $7-plus 2026 profit target while flagging macro uncertainty. Investors awaited his afternoon conference remarks.
Markets 4d ago
Coherent Shares Slide as Bain Capital Affiliate Files to Offload $2.2 Billion Stake
Coherent Corp stock fell over 4% after a Bain Capital affiliate filed to sell 9.4 million shares worth approximately $2.22 billion, marking another significant secondary offering following disposals in late 2025.
Markets 4d ago
Goldman Sachs Gains on CEO's Optimistic Deal Outlook Amid Private Equity Pressure
Goldman Sachs shares climbed 0.6% to $949.59, outperforming financial ETFs, as CEO David Solomon noted private equity firms are accelerating deals to return capital. Key U.S. jobs and inflation data loom this week.
Markets 4d ago
IREN Shares Retreat Following AI-Driven Rally Amid Strategic Pivot
IREN shares declined 1.6% to $45.42, cooling after a 10.3% surge the prior day. The company reported a Q4 net loss of $155.4 million while securing $3.6 billion in GPU financing for its Microsoft AI partnership.
Earnings 4d ago
JPMorgan Gains on Upbeat Dealmaking Outlook Ahead of Key Economic Data
JPMorgan Chase shares advanced 1.1% as executives highlighted strong M&A and IPO pipelines for 2026 at a UBS conference. Investors are bracing for delayed U.S. jobs and inflation reports this week.
Markets 4d ago
JPMorgan Faces Internal Pushback Over Full-Time Office Mandate
JPMorgan Chase employees warn that resisting CEO Jamie Dimon's five-day office requirement could harm careers, as a petition for hybrid work gains limited traction.
Regulation 4d ago
Lloyds Buyback Progresses Amid Barclays Capital Return Pressure
Lloyds Banking Group continues its £1.75 billion share repurchase program, while Barclays' enhanced capital return targets intensify focus on UK bank profitability ahead of key economic data.
Markets 5d ago
Goldman Sachs Gains After Hours on Bullish IPO Outlook, Markets Eye Key Data
Goldman Sachs shares rose 1.6% in extended trading as analysts projected U.S. IPO proceeds could reach $160 billion by 2026. Major economic data on jobs and inflation due this week.
Markets 5d ago
JPMorgan Shares Steady Near $322 as Traders Eye Key Economic Data
JPMorgan Chase shares held near $322.10 in after-hours trading, slightly lagging peers as markets await delayed jobs figures and Friday's CPI report, which will shape interest rate expectations.
Markets 5d ago
Morgan Stanley Gains on Grimes Appointment, Markets Eye Economic Data
Morgan Stanley shares advanced nearly 2% after the bank reinstated veteran dealmaker Michael Grimes to lead investment banking. Investors are monitoring upcoming U.S. jobs and inflation reports for market direction.
Markets 5d ago
Goldman Sachs Gains on Optimistic 2026 IPO Market Forecast
Goldman Sachs shares rose 1.6% Monday, outperforming the financial sector after the bank projected a potential $160 billion U.S. IPO market rebound this year.
IPO 5d ago
JPMorgan Gains Ahead of Key Economic Data and Apple Card Transition
JPMorgan shares advanced 1.1% as bank stocks rose ahead of upcoming payroll and inflation reports. The bank is also preparing to assume Apple Card operations from Goldman Sachs.
Markets 5d ago
Dow Futures Hold Steady Above 50,000 as Key Inflation, Jobs Data Loom
Dow Jones futures were little changed early Monday following the index's historic close above 50,000, with investors awaiting delayed U.S. jobs and inflation reports later this week.
Markets 6d ago
Goldman Sachs Shares Surge on AI Partnership and Market Milestone
Goldman Sachs stock rose 4.3% as the Dow surpassed 50,000, fueled by an AI automation deal with Anthropic and strong capital markets activity.
Markets 6d ago
Financial Stocks Rally Ahead of Key Inflation and Jobs Data
Financial stocks surged as the Dow crossed 50,000, led by major banks and crypto-linked firms. Investors now await delayed January jobs and CPI reports to gauge the Fed's rate path.
Markets 6d ago
Citigroup Surges 6% on Regulatory Progress, Eyes Key Data and Conferences
Citigroup shares rallied 6% Friday amid optimism over resolving long-standing consent orders. The bank also announced a $2.3 billion preferred stock redemption and employee account matching.
Regulation Feb 7
Goldman Sachs Surges on AI Partnership, Lifts Dow Past 50,000
Goldman Sachs shares climbed 4.3% Friday following confirmation of an AI collaboration with Anthropic, helping propel the Dow Jones Industrial Average above 50,000 for the first time. Key economic data releases and new structured note filings are in focus.
Markets Feb 7
Financial Stocks Surge as Dow Tops 50,000; Fed Signals and Data in Focus
U.S. financial shares rallied Friday, with the XLF ETF climbing 1.8% and the Dow closing above 50,000. Key inflation and jobs reports due next week will test the sector's momentum.
Markets Feb 7
Abpro Holdings Shares Tumble in Premarket Following Goldman Sachs Stake Disclosure
Abpro Holdings shares fell sharply in premarket trading after a regulatory filing revealed Goldman Sachs holds a 6.8% stake in the biotech firm. The stock experienced extreme volatility with trading volume surging to 74.3 million shares.
Markets 4d ago
Ondas Secures $30M+ Israeli Demining Contract, Goldman Sachs Holds 4.2% Stake
Ondas Holdings shares held steady in premarket trading after its 4M Defense unit won a demining contract valued over $30 million in Israel. Goldman Sachs disclosed a 4.2% passive stake in the company.
Technology 4d ago
Abpro Holdings Soars 94% Premarket on Goldman Sachs Stake Disclosure
Abpro Holdings shares surged nearly 94% in premarket trading after a regulatory filing revealed Goldman Sachs holds a 6.8% passive stake in the biotech firm.
Markets 5d ago
Arrowhead Sees Volatility After S&P MidCap 400 Inclusion, Goldman Eyes 2026 Pipeline
Arrowhead Pharmaceuticals shares experienced heightened trading activity and a slight decline following its transition to the S&P MidCap 400 index. Goldman Sachs reiterated a Neutral stance, highlighting pivotal 2026 clinical data and competitive pressures.
Markets 5d ago